{"nctId":"NCT02509078","briefTitle":"Reevaluation Of Systemic Early Neuromuscular Blockade","startDateStruct":{"date":"2016-01-04","type":"ACTUAL"},"conditions":["Acute Respiratory Distress Syndrome"],"count":1008,"armGroups":[{"label":"Early Neuromuscular Blockade (NMB)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Cisatracurium Besylate"]},{"label":"Control: No Routine Early NMB","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Cisatracurium Besylate","otherNames":["Nimbex"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria\n\n1. Age \\> 18 years\n2. Presence of all of the following conditions for \\< 48 hours:\n\n   i. PaO2/FiO2 \\< 150 with PEEP \\>/= 8 cm H2O OR, if ABG not available, SaO2/FiO2 ratio that is equivalent to a PaO2/FiO2 \\< 150 with PEEP \\>/= 8 cm H2O , and a confirmatory SaO2/FiO2 ratio that is again equivalent 1-6 hours later\n\nii. Bilateral opacities not fully explained by effusions, lobar/lung collapse, or nodules.\n\niii. Respiratory failure not fully explained by cardiac failure or fluid overload; need objective assessment (e.g., echocardiography) to exclude hydrostatic edema if no risk factor present.\n\nPatients must be enrolled within 48 hours of meeting inclusion criteria.\n\nExclusion Criteria:\n\n1. Lack of informed consent\n2. Continuous neuromuscular blockade at enrollment\n3. Known pregnancy\n4. Currently receiving ECMO therapy\n5. Chronic respiratory failure defined as PaCO2 \\> 60 mm Hg in the outpatient setting\n6. Home mechanical ventilation (non-invasive ventilation or via tracheotomy) except for CPAP/BIPAP used solely for sleep-disordered breathing\n7. Actual body weight exceeding 1 kg per centimeter of height\n8. Severe chronic liver disease defined as a Child-Pugh score of 12-15 (Appendix A2)\n9. Bone marrow transplantation within the last 1 year\n10. Expected duration of mechanical ventilation of \\< 48 hours\n11. Decision to withhold life-sustaining treatment; except in those patients committed to full support except cardiopulmonary resuscitation if an actual cardiac arrest occurs\n12. Moribund patient not expected to survive 24 hours; if CPR provided, assess for moribund status greater than 6 from CPR conclusion\n13. Diffuse alveolar hemorrhage from vasculitis\n14. Burns \\> 70% total body surface\n15. Unwillingness to utilize the ARDS Network 6 ml/kg IBW ventilation protocol\n16. Previous hypersensitivity or anaphylactic reaction to cisatracurium\n17. Neuromuscular conditions that may potentiate neuromuscular blockade and/or impair spontaneous ventilation (Appendix A2)\n18. Neurologic conditions undergoing treatment for intracranial hypertension\n19. Enrollment in an interventional ARDS trial with direct impact on neuromuscular blockade and PEEP\n20. \\>120 hours of mechanical ventilation\n21. P/F \\< 200 mmHg at the time of randomization (if available)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Hospital Mortality to Day 90","description":"The percentage of subjects alive at study day 90. Those subjects discharged home prior to day 90 were counted as alive at day 90.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"288","spread":null},{"groupId":"OG001","value":"289","spread":null}]},{"measurements":[{"groupId":"OG000","value":"213","spread":null},{"groupId":"OG001","value":"216","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Ventilator Free Days to Day 28","description":"Ventilator-free days is defined to be 28 days minus the duration of mechanical ventilation through day 28. Participants who do not survive to day 28 are assigned zero ventilator-free days.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.6","spread":"10.4"},{"groupId":"OG001","value":"9.9","spread":"10.9"}]}]}]},{"type":"SECONDARY","title":"Mean Organ Failure Free Days to Day 28","description":"SOFA (Sepsis-related Organ Failure Assessment) was used to determine criteria for an organ failure free day. Scores were based on four of the six SOFA organ categories: Coagulation, Liver, Cardiovascular, and Renal. Each category was scored 0-4; 0 being normal functioning and 4 being the most abnormal. A patient was considered failure free on each day alive with SOFA scores below 2 for all four organ systems.\n\nRef: Vincent, J.L., et al., The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med, 1996. 22(7): p. 707-10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.4","spread":"11.3"},{"groupId":"OG001","value":"12.5","spread":"11.5"}]}]}]},{"type":"SECONDARY","title":"ICU Free Days to Day 28","description":"ICU free days is defined as the number of days between randomization and day 28 in which the patient is in the ICU (for any part of a day).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.0","spread":"9.4"},{"groupId":"OG001","value":"9.4","spread":"9.8"}]}]}]},{"type":"SECONDARY","title":"Mean Hospital Free Days to Days 28","description":"Hospital free days are days alive post hospital discharge through day 28. Patients who die on or prior to day 28 are assigned zero hospital free days.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.7","spread":"7.8"},{"groupId":"OG001","value":"5.9","spread":"8.1"}]}]}]},{"type":"SECONDARY","title":"Katz Activities of Daily Living (ADL)/Lawton Instrumental Activities Of Daily Living Scale (IADL)","description":"Assesses whether individual can living independently and assess a range of common functional activities, from walking and toileting to managing money and cooking meals. Data is a pooled estimates from patient survey and proxy survey. The total score is rated from 0 to 10 (MCID=1; 1 point=1 ADL); a higher score indicates having more difficulties in daily activities.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":"2.7"},{"groupId":"OG001","value":"3.0","spread":"2.7"}]}]}]},{"type":"SECONDARY","title":"EuroQol (EQ-5D-5L): Health Related Quality of Life","description":"Using a standardized scale, do health reasons limit the person's ability to enjoy their life? Pooled estimates from patient survey and proxy survey were used. Utility index was computed from a lookup table according to EQ-5D-5L response profiles; utility index ranges from -0.11 to 1.00 (higher scores are better; 1.00 is perfect health), minimal clinically important difference (MCID) is 0.07","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.66","spread":null},{"groupId":"OG001","value":"0.73","spread":null}]}]}]},{"type":"SECONDARY","title":"PTSS-14: Post-traumatic Stress-like Symptoms Scores >/= 45","description":"Does the patient have symptoms of anxiety and stress from their ICU stay? PTSS-14 is only asked at month 6 and month 12 in patient survey; total score is rated from 14 to 98 and a higher score indicates having more post-traumatic stress syndrome related symptoms. Participants with scores greater than or equal to 45 were reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null},{"groupId":"OG001","value":"31","spread":null}]}]}]},{"type":"SECONDARY","title":"MoCA-Blind: Montreal Cognitive Assessment","description":"How clearly can patient think and recall things? MoCA-Blind is only asked in patient survey; total score is rated from 0 to 30 and a higher score indicates better cognitive performance. Normal range: 26 or greater.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.2","spread":"5.2"},{"groupId":"OG001","value":"22.8","spread":"4.8"}]}]}]},{"type":"SECONDARY","title":"Katz Activities of Daily Living (ADL)/Lawton Instrumental Activities Of Daily Living Scale (IADL)","description":"Assesses whether individual can living independently and assess a range of common functional activities, from walking and toileting to managing money and cooking meals. Data is a pooled estimates from patient survey and proxy survey. The total score is rated from 0 to 10 (MCID=1; 1 point=1 ADL); a higher score indicates having more difficulties in daily activities.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":"2.4"},{"groupId":"OG001","value":"2.7","spread":"2.4"}]}]}]},{"type":"SECONDARY","title":"Katz Activities of Daily Living (ADL)/Lawton Instrumental Activities Of Daily Living Scale (IADL)","description":"Assesses whether individual can living independently and assess a range of common functional activities, from walking and toileting to managing money and cooking meals. Data is a pooled estimates from patient survey and proxy survey. The total score is rated from 0 to 10 (MCID=1; 1 point=1 ADL); a higher score indicates having more difficulties in daily activities.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.9","spread":"2.6"},{"groupId":"OG001","value":"2.4","spread":"2.3"}]}]}]},{"type":"SECONDARY","title":"EuroQol (EQ-5D-5L): Health Related Quality of Life","description":"Using a standardized scale, do health reasons limit the person's ability to enjoy their life? Pooled estimates from patient survey and proxy survey were used. Utility index was computed from a lookup table according to EQ-5D-5L response profiles; utility index ranges from -0.11 to 1.00 (higher scores are better; 1.00 is perfect health), minimal clinically important difference (MCID) is 0.07","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.74","spread":null},{"groupId":"OG001","value":"0.79","spread":null}]}]}]},{"type":"SECONDARY","title":"EuroQol (EQ-5D-5L): Health Related Quality of Life","description":"Using a standardized scale, do health reasons limit the person's ability to enjoy their life? Pooled estimates from patient survey and proxy survey were used. Utility index was computed from a lookup table according to EQ-5D-5L response profiles; utility index ranges from -0.11 to 1.00 (higher scores are better; 1.00 is perfect health), minimal clinically important difference (MCID) is 0.07","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.75","spread":null},{"groupId":"OG001","value":"0.77","spread":null}]}]}]},{"type":"SECONDARY","title":"MoCA-Blind: Montreal Cognitive Assessment","description":"How clearly can patient think and recall things? MoCA-Blind is only asked in patient survey; total score is rated from 0 to 30 and a higher score indicates better cognitive performance. Normal range:\n\n26 or greater.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.8","spread":"4.8"},{"groupId":"OG001","value":"23.2","spread":"5.1"}]}]}]},{"type":"SECONDARY","title":"MoCA-Blind: Montreal Cognitive Assessment","description":"How clearly can patient think and recall things? MoCA-Blind is only asked in patient survey; total score is rated from 0 to 30 and a higher score indicates better cognitive performance. Normal range:\n\n26 or greater.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23.3","spread":"4.9"},{"groupId":"OG001","value":"24.0","spread":"4.4"}]}]}]},{"type":"SECONDARY","title":"PTSS-14: Post-traumatic Stress-like Symptoms Scores >/= 45","description":"Does the patient have symptoms of anxiety and stress from their ICU stay? PTSS-14 is only asked at month 6 and month 12 in patient survey; total score is rated from 14 to 98 and a higher score indicates having more post-traumatic stress syndrome related symptoms. Participants with scores greater than or equal to 45 were reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"38","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":28,"n":501},"commonTop":["Hypotension","Pneumothorax","Pneumomediastinum","Cardiac Arrest","Hypotension"]}}}